Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
View ORCID ProfileMorihito Takita, Tomoko Matsumura, Kana Yamamoto, Erika Yamashita, Kazutaka Hosoda, Tamae Hamaki, Eiji Kusumi
doi: https://doi.org/10.1101/2020.06.03.20121020
Morihito Takita
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
MD, PhDTomoko Matsumura
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
MD, PhDKana Yamamoto
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
3Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo, 108-0071, Japan
MDErika Yamashita
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
Kazutaka Hosoda
4Department of Pediatrics, Navitas Clinic Tachikawa, Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
MDTamae Hamaki
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
MDEiji Kusumi
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
MD
Article usage
Posted June 04, 2020.
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
Morihito Takita, Tomoko Matsumura, Kana Yamamoto, Erika Yamashita, Kazutaka Hosoda, Tamae Hamaki, Eiji Kusumi
medRxiv 2020.06.03.20121020; doi: https://doi.org/10.1101/2020.06.03.20121020
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
Morihito Takita, Tomoko Matsumura, Kana Yamamoto, Erika Yamashita, Kazutaka Hosoda, Tamae Hamaki, Eiji Kusumi
medRxiv 2020.06.03.20121020; doi: https://doi.org/10.1101/2020.06.03.20121020
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)